Literature DB >> 6191422

Prostatic hypertrophy and venereal disease as possible risk factors in the development of bladder cancer.

S Mommsen, A Sell.   

Abstract

In three urological predictors, nocturia, prostatic surgery for prostatic hypertrophy and a previous venereal disease, a significantly increased relative risk (RR) of developing bladder cancer was detected. An epidemiological case control investigation was performed on 165 male bladder cancer patients and an equal number of male controls matched concerning age and geographical area. The sample was obtained from a predominantly rural district. The theoretical individual risk factors were calculated by the aid of a multivariate logistic analysis. Twenty-four patients versus 11 controls had a history of prostatic surgery (RR = 2.38) for benign prostatic hypertrophy, 60 patients versus 36 controls complained of nocturia at least 2 years before presenting symptoms of bladder cancer (RR = 2.05), and 16 patients versus seven controls had a history of venereal disease (RR = 2.42). The results seems to indicate that prostatic hypertrophy and previous venereal disease may at least in part be factors of importance associated with bladder cancer.

Entities:  

Mesh:

Year:  1983        PMID: 6191422     DOI: 10.1007/bf00256946

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  11 in total

1.  Pre-cancerous changes in bladder epithelium.

Authors:  R O Schade; J Swinney
Journal:  Lancet       Date:  1968-11-02       Impact factor: 79.321

2.  Rates, interview, and pathology study of cancer of the urinary bladder in New Orleans, Louisiana.

Authors:  L J Dunham; A S Rabson; H L Stewart; A S Frank; J L Young
Journal:  J Natl Cancer Inst       Date:  1968-09       Impact factor: 13.506

3.  The evolving case-control study.

Authors:  P Cole
Journal:  J Chronic Dis       Date:  1979

4.  Are doctors able to assess prostatic size?

Authors:  H H Meyhoff; T Hald
Journal:  Scand J Urol Nephrol       Date:  1978

5.  Pre-prostatectomy excretory urography: does it merit the expense?

Authors:  B D Pinck; M J Corrigan; P Jasper
Journal:  J Urol       Date:  1980-03       Impact factor: 7.450

6.  [Flat intraepithelial carcinoma in situ per se in the bladder. Symptoms and course in 4 patients].

Authors:  S Mommsen; F Jocobsen
Journal:  Ugeskr Laeger       Date:  1982-04-12

7.  Tobacco use, occupation, coffee, various nutrients, and bladder cancer.

Authors:  G R Howe; J D Burch; A B Miller; G M Cook; J Esteve; B Morrison; P Gordon; L W Chambers; G Fodor; G M Winsor
Journal:  J Natl Cancer Inst       Date:  1980-04       Impact factor: 13.506

8.  The association between vesical carcinoma and urinary obstruction.

Authors:  G J Fellows
Journal:  Eur Urol       Date:  1978       Impact factor: 20.096

9.  Excretory urography. A superfluous routine examination in patients with prostatic hypertrophy?

Authors:  I Christoffersen; I Møller
Journal:  Eur Urol       Date:  1981       Impact factor: 20.096

10.  An epidemiological case-control study of bladder cancer in males from a predominantly rural district.

Authors:  S Mommsen; J Aagaard; A Sell
Journal:  Eur J Cancer Clin Oncol       Date:  1982-11
View more
  8 in total

1.  Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study.

Authors:  Chu-Wen Fang; Cheng-Hsi Liao; Shih-Chi Wu; Chih-Hsin Muo
Journal:  World J Urol       Date:  2018-02-09       Impact factor: 4.226

Review 2.  Role of bacteria in oncogenesis.

Authors:  Alicia H Chang; Julie Parsonnet
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

3.  Low level exposure to monomethyl arsonous acid-induced the over-production of inflammation-related cytokines and the activation of cell signals associated with tumor progression in a urothelial cell model.

Authors:  C Escudero-Lourdes; M K Medeiros; M C Cárdenas-González; S M Wnek; J A Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2010-01-04       Impact factor: 4.219

4.  Gonorrhoea and male bladder cancer in a prospective study.

Authors:  D S Michaud; E A Platz; E Giovannucci
Journal:  Br J Cancer       Date:  2006-12-12       Impact factor: 7.640

5.  Simultaneous transurethral resection of bladder cancer and prostate may reduce recurrence rates: A systematic review and meta-analysis.

Authors:  Sheng Li; Xian-Tao Zeng; Xiao-Lan Ruan; Xing-Huan Wang; Yi Guo; Zhong-Hua Yang
Journal:  Exp Ther Med       Date:  2012-08-09       Impact factor: 2.447

6.  Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan.

Authors:  Chin-Hsiao Tseng
Journal:  BMC Cancer       Date:  2013-01-04       Impact factor: 4.430

7.  Urinary tract infections and reduced risk of bladder cancer in Los Angeles.

Authors:  X Jiang; J E Castelao; S Groshen; V K Cortessis; D Shibata; D V Conti; J-M Yuan; M C Pike; M Gago-Dominguez
Journal:  Br J Cancer       Date:  2009-01-27       Impact factor: 7.640

8.  Benign prostatic hyperplasia and subsequent risk of bladder cancer.

Authors:  D Kang; A P Chokkalingam; G Gridley; O Nyren; J E Johansson; H O Adami; D Silverman; A W Hsing
Journal:  Br J Cancer       Date:  2007-05-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.